377 related articles for article (PubMed ID: 1692065)
21. Basic characteristics of human lung mast cell desensitization.
MacGlashan D; Lichtenstein LM
J Immunol; 1987 Jul; 139(2):501-5. PubMed ID: 2439588
[TBL] [Abstract][Full Text] [Related]
22. The effect of interleukin 3 upon IgE-dependent and IgE-independent basophil degranulation and leukotriene generation.
Kurimoto Y; De Weck AL; Dahinden CA
Eur J Immunol; 1991 Feb; 21(2):361-8. PubMed ID: 1705512
[TBL] [Abstract][Full Text] [Related]
23. Maitotoxin, a novel activator of mediator release from human basophils, induces large increases in cytosolic calcium resulting in histamine, but not leukotriene C4, release.
Columbo M; Taglialatela M; Warner JA; MacGlashan DW; Yasumoto T; Annunziato L; Marone G
J Pharmacol Exp Ther; 1992 Dec; 263(3):979-86. PubMed ID: 1281881
[TBL] [Abstract][Full Text] [Related]
24. RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils.
Kuna P; Reddigari SR; Schall TJ; Rucinski D; Viksman MY; Kaplan AP
J Immunol; 1992 Jul; 149(2):636-42. PubMed ID: 1378073
[TBL] [Abstract][Full Text] [Related]
25. Protein Fv produced during vital hepatitis is a novel activator of human basophils and mast cells.
Patella V; Bouvet JP; Marone G
J Immunol; 1993 Nov; 151(10):5685-98. PubMed ID: 7693815
[TBL] [Abstract][Full Text] [Related]
26. Cyclosporin A inhibits the release of histamine and peptide leukotriene C4 from human lung mast cells.
Marone G; Triggiani M; Cirillo R; Giacummo A; Siri L; Condorelli M
Ric Clin Lab; 1988; 18(1):53-9. PubMed ID: 2453912
[TBL] [Abstract][Full Text] [Related]
27. Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell.
Undem BJ; Peachell PT; Lichtenstein LM
J Pharmacol Exp Ther; 1988 Oct; 247(1):209-17. PubMed ID: 2459368
[TBL] [Abstract][Full Text] [Related]
28. Release of histamine from human leukocytes stimulated with the tumor-promoting phorbol diesters. II. Interaction with other stimuli.
Schleimer RP; Gillespie E; Daiuta R; Lichtenstein LM
J Immunol; 1982 Jan; 128(1):136-40. PubMed ID: 6172475
[TBL] [Abstract][Full Text] [Related]
29. Modulation of mediator release from human basophils and pulmonary mast cells and macrophages by auranofin.
Columbo M; Galeone D; Guidi G; Kagey-Sobotka A; Lichtenstein LM; Pettit GR; Marone G
Biochem Pharmacol; 1990 Jan; 39(2):285-91. PubMed ID: 2105731
[TBL] [Abstract][Full Text] [Related]
30. Inhibition by somatostatin of the release of mediators from human basophils and rat leukemic basophils.
Goetzl EJ; Payan DG
J Immunol; 1984 Dec; 133(6):3255-9. PubMed ID: 6208274
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of basophil histamine release by anti-inflammatory steroids. II. Studies on the mechanism of action.
Schleimer RP; MacGlashan DW; Gillespie E; Lichtenstein LM
J Immunol; 1982 Oct; 129(4):1632-6. PubMed ID: 6180017
[TBL] [Abstract][Full Text] [Related]
32. Anti-allergic properties of cyclosporin A: inhibition of mediator release from human basophils and rat basophilic leukemia cells (RBL-2H3).
Ezeamuzie CI; Assem ES
Immunopharmacology; 1990; 20(1):31-43. PubMed ID: 1699910
[TBL] [Abstract][Full Text] [Related]
33. Histamine release from human basophils by synthetic block co-polymers composed of polyoxyethylene and polyoxypropylene and synergy with immunologic and non-immunologic stimuli.
Atkinson TP; Smith TF; Hunter RL
J Immunol; 1988 Aug; 141(4):1307-10. PubMed ID: 2456350
[TBL] [Abstract][Full Text] [Related]
34. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release.
Stellato C; Cirillo R; de Paulis A; Casolaro V; Patella V; Mastronardi P; Mazzarella B; Marone G
Anesthesiology; 1992 Nov; 77(5):932-40. PubMed ID: 1280014
[TBL] [Abstract][Full Text] [Related]
35. Antiinflammatory effect of FK 506 on human basophils.
de Paulis A; Cirillo R; Ciccarelli A; Columbo M; Marone G
Transplant Proc; 1991 Dec; 23(6):2905-6. PubMed ID: 1721309
[No Abstract] [Full Text] [Related]
36. IgE-dependent IL-4 secretion by human basophils. The relationship between cytokine production and histamine release in mixed leukocyte cultures.
Schroeder JT; MacGlashan DW; Kagey-Sobotka A; White JM; Lichtenstein LM
J Immunol; 1994 Aug; 153(4):1808-17. PubMed ID: 7519213
[TBL] [Abstract][Full Text] [Related]
37. Ionic regulation of human basophil releasability. III. Effects of Na+ and Ca2+ on histamine release induced by different stimuli.
Tedeschi A; Palella M; Arquati M; Milazzo N; Miadonna A
Pharmacol Res; 1994; 30(3):229-41. PubMed ID: 7532302
[TBL] [Abstract][Full Text] [Related]
38. Modulation of histamine release from human basophils in vitro by physiological concentrations of zinc.
Marone G; Findlay SR; Lichtenstein LM
J Pharmacol Exp Ther; 1981 May; 217(2):292-8. PubMed ID: 6164779
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of histamine, leukotriene C4/D4, and thromboxane B2 release from human leukocytes and human chopped lung mast cells by the allergic mediator release inhibitor, CI-949.
Conroy MC; Kennedy JA; Chestnut JC; Wright CD; Adolphson RL; Thueson DO
J Allergy Clin Immunol; 1990 Dec; 86(6 Pt 1):902-8. PubMed ID: 1702129
[TBL] [Abstract][Full Text] [Related]
40. Cord blood basophil releasability: evaluation of histamine release and leukotriene C4 generation.
Miadonna A; Leggieri E; Tedeschi A; Lorini M; Motta G; Lucci G; Froldi M; Marini A; Zanussi C
Int Arch Allergy Appl Immunol; 1988; 86(1):42-7. PubMed ID: 2453473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
